1
|
Kus T, Aktas G, Kalender M, Sevinc A, Camci C. P53 and ERCC1 gene polymorphisms can predict the recurence risk of breast cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw364.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
2
|
Kalender M, Bulbul F, Aktas G, Kus T, Okyar B, Balakan O, Camci C. Awareness of cancer diagnosis in Turkish patients can increase anxiety and depression: is it true? Ann Oncol 2016. [DOI: 10.1093/annonc/mdw390.72] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
3
|
Kalender ME, Cakir M, Ergun S, Oztuzcu S, Cengiz B, Ulasli M, Sevinc A, Camci C. Abstract P6-08-08: Expression and role of ING3 gene in breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p6-08-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Inhibitor of growth (ING) tumor suppressor gene family has been discovered over the past decade and five different genes have been identified from ING1 to ING5. They have some functions like cell transcription regulation, cell cycle control, DNA repair and apoptosis. Because of the fact that ING3 gene expression has not been studied in breast cancer so far, we aimed to determine whether there was a relationship between ING3 gene expression and breast cancer prognostic factors.
Methods: 46 female breast cancer patients in different stages were enrolled to our study. ING3 gene expressions obtained from tumoral and healthy breast tissue samples of patients were evaluated together with pathological and histological parameters.
Results: The median age of the patients was 49 years. ING3 expression rate has been significantly higher in the tumor tissue compared to normal tissue and was statistically significant (p=0.001). In estrogen receptor (ER) and progesterone receptor (PR) positive patients, gene expression ratio was significantly higher than negative ones (p<0.001 and p<0.001, respectively). ING3 expression in tumor tissues of the patients with advanced disease (stage 3-4) was detected higher than ones with early stage disease and it was found to be statistically significant at the border (p=0.048). Moreover, there were no significant changes when ING3 gene expressions were compared with c-erbB2 (Receptor tyrosine-protein kinase erbB-2) status and tumor grade (p> 0.05).
Conclusions: This study was the first study on ING3 gene expression in breast cancer. ING3 gene expression has been shown to be associated with the receptor positivity and advanced stage disease. Further studies should be conducted on the prognostic significance of ING3 gene in breast cancer.
Citation Format: Kalender ME, Cakir M, Ergun S, Oztuzcu S, Cengiz B, Ulasli M, Sevinc A, Camci C. Expression and role of ING3 gene in breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-08-08.
Collapse
Affiliation(s)
- ME Kalender
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - M Cakir
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - S Ergun
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - S Oztuzcu
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - B Cengiz
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - M Ulasli
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - A Sevinc
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - C Camci
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| |
Collapse
|
4
|
Kalender M, Kuzhan A, Dirier A, Suner A, Camci C. 1544 The impact of smoking on smoking related cancer patients' relatives': Perspective in the Turkish society. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30634-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
5
|
Sozucan Y, Kalender ME, Sari I, Suner A, Oztuzcu S, Arman K, Yumrutas O, Bozgeyik I, Cengiz B, Igci YZ, Balakan O, Camci C. TRP genes family expression in colorectal cancer. Exp Oncol 2015; 37:208-212. [PMID: 26422106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
UNLABELLED Colorectal cancer (CRC) is the most common cancer of the gastrointestinal tract. Different factors are responsible for the development of CRC. Transient Receptor Potential (TRP) which is an important component of calcium channel is associated with several pathological conditions like cancer, neurodegenerative and cardiovascular diseases. Thirty members of the family of TRP ion channel in mammals have been determined till now. The aim of this study is to investigate TRPM, TRPV and TRPC gene expression levels in tumor tissues of CRC patients and to analyze the relationship of expression in tumor tissue of CRC with other known prognostic factors. MATERIAL AND METHODS In this study, 93 CRC patients were included. The level of TRP gene expression in paraffin blocks of normal and cancerous colorectal tissue samples were studied at the level of mRNA with Real-time PCR. RESULTS The mRNA expression level of TRPV3, TRPV4, TRPV5, TRPM4 and TRPC6 genes in 37 female and 56 male patients diagnosed with CRC was revealed lower in tumor tissue as compared to normal tissue (p < 0.05). No statistically significant differences of mRNA expression levels of other TRP genes were found. CONCLUSIONS TRP gene family like TRPV3, TRPV4, TRPV5, TRPM4 and TRPC6 may be thought as potential genes contributing to tumorigenesis as their expression decreases in CRC as compared to normal tissues.
Collapse
Affiliation(s)
- Y Sozucan
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - M E Kalender
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - I Sari
- Department of Pathology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - A Suner
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - S Oztuzcu
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - K Arman
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - O Yumrutas
- Department of Medical Biology, Faculty of Medicine, Adiyaman University, Adiyaman TR-02040, Turkey
| | - I Bozgeyik
- Department of Medical Biology, Faculty of Medicine, Adiyaman University, Adiyaman TR-02040, Turkey
| | - B Cengiz
- Department of Medical Biology, Faculty of Medicine, Gazi University, Ankara TR-06560, Turkey
| | - Y Z Igci
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - O Balakan
- Department of Medical Oncology, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, TR-46100, Turkey
| | - C Camci
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| |
Collapse
|
6
|
Alptekin M, Eroglu S, Tutar E, Sencan S, Geyik MA, Ulasli M, Demiryurek AT, Camci C. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival. Tumour Biol 2015; 36:9209-13. [PMID: 26088448 DOI: 10.1007/s13277-015-3577-x] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2015] [Accepted: 05/15/2015] [Indexed: 12/14/2022] Open
Abstract
Glioblastoma multiforme (GBM) is one of the most lethal forms of cancer in humans, with a median survival of 10 to 12 months. Glioblastoma is highly malignant since the cells are supported by a great number of blood vessels. Although new treatments have been developed by increasing knowledge of molecular nature of the disease, surgical operation remains the standard of care. The TRP (transient receptor potential) superfamily consists of cation-selective channels that have roles in sensory physiology such as thermo- and osmosensation and in several complex diseases such as cancer, cardiovascular, and neuronal diseases. The aim of this study was to investigate the expression levels of TRP channel genes in patients with glioblastoma multiforme and to evaluate the relationship between TRP gene expressions and survival of the patients. Thirty-three patients diagnosed with glioblastoma were enrolled to the study. The expression levels of 21 TRP genes were quantified by using qRT-PCR with dynamic array 48 × 48 chip (BioMark HD System, Fluidigm, South San Francisco, CA, USA). TRPC1, TRPC6, TRPM2, TRPM3, TRPM7, TRPM8, TRPV1, and TRPV2 were found significantly higher in glioblastoma patients. Moreover, there was a significant relationship between the overexpression of TRP genes and the survival of the patients. These results demonstrate for the first time that TRP channels contribute to the progression and survival of the glioblastoma patients.
Collapse
Affiliation(s)
- M Alptekin
- Department of Neurosurgery, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - S Eroglu
- Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - E Tutar
- Department of Pathology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - S Sencan
- Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - M A Geyik
- Department of Neurosurgery, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - M Ulasli
- Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - A T Demiryurek
- Department of Pharmacology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - C Camci
- Department of Medical Oncology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey.
| |
Collapse
|
7
|
Camci C, Ergun S, Temiz E, Kirkbes S, Ulasli M, Oztuzcu S. Advancing Apoptosis by MIR-122-5P in Combination with Trastuzumab in SKBR3 Cell Line. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu467.7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Akbulut H, Altundag MK, Saip P, Coskun HS, Camci C, Ozkan M, Paydas S, Zengin N, Alco G, Aliustaoglu M, Basaran G, Yamac D, Yucel I, Goker E, Yaman E, Isikdogan A, Ozisik YY, Topuz E, Ozdogan M, Icli F. The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e12007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
9
|
Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S. Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.3579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
10
|
Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S. A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.474] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
474 Background: Colorectal cancer is one of the most frequent malignancies, second to breast cancer in women and third to lung cancer and prostate cancer in men. The aim of this study in first-line metastatic colorectal cancer (mCRC) was to achieve a better progression-free survival (PFS) and less risk of toxicity by administrating bevacizumab (BEV) + capecitabine + oxaliplatin (XELOX) for 6 cycles, stop oxaliplatin and go with maintenance therapy (BEV + capecitabine) until progression. Methods: BEV (7.5 mg/kg) + XELOX (capecitabine 1,000 mg/m2 bid d1–14 + oxaliplatin 130 mg/m2 d1 q3w) were administered until progression (Arm A) or 6 cycles of BEV + XELOX followed by BEV + capecitabine were administered until progression (Arm B). PFS was the primary endpoint; secondary endpoints included overall survival (OS), objective response rate (ORR), and safety. A sample size of 118 patients (pts) was calculated to achieve 80% power to detect an increase of 1.5 months in median PFS between Arm A (9.5 months) and Arm B (11.0 months) with a standard deviation of 3.9 months and significance level of 0.05 using a 10% drop-out rate. Results: A total of 122 pts were randomized. No significant differences were found in demographic characteristics between the two arms. Median treatment period was 6.1 (range 0.7–13.4) and 6.8 (range 0.7–12.4) months in Arms A and B, respectively. Interim analysis showed no statistically significant differences in median PFS and ORR between arms (see table). Tolerability was also acceptable in both arms with grade 3/4 diarrhoea in 7.7% vs. 8.2%, weakness in 15.2% vs. 8.4%, hand-foot syndrome in 6.3% vs. 9.4%, and neuropathy in 2.8% vs. 4.6% of pts in Arms A and B, respectively. Conclusions: BEV + capecitabine as maintenance therapy following induction BEV + XELOX is non-inferior to continuous BEV + XELOX until progression. While this study is ongoing, these interim findings suggest that maintenance therapy with BEV + capecitabine is an appropriate option following induction BEV + XELOX in pts with mCRC. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- S. Yalcin
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - R. Uslu
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - F. Dane
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - U. Yilmaz
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - N. Zengin
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - E. Buyukunal
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - S. Buyukberber
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - C. Camci
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - O. Sencan
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - S. Kilickap
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| |
Collapse
|
11
|
Aykan N, Demir G, Disci R, Yalcin S, Turhal NS, Ozdogan M, Ozkan M, Yaren A, Camci C, Akbulut H. Profile of the colorectal (CRC) cancer (Ca) patients (PTS) in Turkey: A cross-sectional disease registry study—A Turkish Oncology Group trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
394 Background: CRC Ca is one of the most common Ca worldwide. This study was designed to determine the profile of recently diagnosed CRC Ca pts in Turkey. Methods: In this national, multicenter cross-sectional disease registry study, data for 968 pts diagnosed CRC Ca were analyzed. This non-interventional study was supported by sanofi-aventis. Results: From October 2008 to October 2009, 662 colon (68%), 306 rectum (32%) Ca pts were registered from 21 centers in 7 geographic regions of Turkey. Characteristics are as follows. Male 61%, mean age was 60±12 for colon and 57±13 for rectum Ca. The ratio of colon and rectum Ca were equal in the Black Sea region, colon Ca was higher in the other 5 regions except Eastern Anatolia where the highest percentage of rectum Ca was observed (55% vs 45%). Red meat consumption was significantly high only in Eastern Anatolia (p<0.001). The consumption of alcohol, fruit and vegetables didn't show any difference. The percentage of smoking was slightly higher in the rectum Ca group (21% vs 16%, NS). The CRC family history was a risk factor in 7.4% colon, and in 5.6% rectum Ca pts. Among all pts, 1.5% had familial poliposis and only 0.4% had Lynch syndrome. Hypertension (29%) and diabetes mellitus (15%) were the most frequent concomitant diseases. Mean body mass index was 26 ± 4 in colon and 26 ± 5 in rectum Ca pts. Median time between the onset of symptoms and diagnosis was 3 months (mo) for colon and 4 mo for rectum Ca pts. For 46% of pts this time was longer than 4 mo. The mean weight loss in last 6 mo was slightly higher in colon Ca pts (3.9 vs 3.4 kg). Anemia was more frequent in colon Ca pts (p<0.05). Primary tumor location: sigmoid 37% for colon Ca, distal rectum 61% for rectum Ca. In total, 86% of pts were operated (88% of colon, 80% of rectum Ca). In 26% of pts emergency surgery was performed. AJCC staging at diagnosis: I-7%, II-26%, III-35%, IV-32% in colon and I-14%, II-22%, III-39%, IV:25% in rectum. Conclusions: This study showed that colon Ca was more frequent and most of the cases were operated. Data also revealed that pts were diagnosed at considerably later stages. The role of the consumption of red meat, obesity and smoking should be evaluated in larger trial in the future. [Table: see text]
Collapse
Affiliation(s)
- N. Aykan
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - G. Demir
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - R. Disci
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - S. Yalcin
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - N. S. Turhal
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - M. Ozdogan
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - M. Ozkan
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - A. Yaren
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - C. Camci
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - H. Akbulut
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | | |
Collapse
|
12
|
Camci C, Firoiu E, Gumus M, Hurtado de Mendoza F, Chavez-Zamudio MA, Davidson N, Brychta M, Donadio M, Soldatenkova V, Benhadji KA. Factors associated with the choice of taxane monotherapy or combination in the management of advanced breast cancer: Results of an international observational study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.1132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
13
|
Kalender M, Demiryürek S, Oztuzcu S, Kizilyer A, Demiryürek A, Sevinc A, Dikilitas M, Yildiz R, Camci C. Association between the Thr431asn Polymorphism of the Rock2 Gene and Breast Cancer. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-09-3038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The objective of this study was to analyze the genotype distributions and allele frequencies for Threonine431Asparagine (Thr431Asn) and Arginine83Lysine (Arg83Lys) polymorphisms of the Rho kinase2 (ROCK2) gene among the breast cancer patients.Material and Methods: In this case-control study, 223 patients with breast cancer were recruited and divided into two groups according to metastases (n=128) and without metastases (n=95). Genomic DNA from the patients and the control cases (n=150) was analyzed by real-time PCR using a Light-Cycler.Results: Neither genotype distributions nor the allele frequencies for the Arg83Lys polymorphism showed a significant difference between the groups. Although no marked changes was observed with no metastasis group, a statistically significant association was found between the control and metastatic group for the Thr431Asn polymorphism of the ROCK2 gene. Further analysis revealed that there were marked associations of this polymorphism with bone, liver, and lung metastases. Homozygous carriers of the Thr431Thr genotype were more frequent among the metastatic patients (39.8%) than among controls (26.0%; P =0.0485). There was also an increase in Thr431 allele (60.5% in patients vs 51.7% in controls) and decrease in Asn431 allele frequencies (48.3% in control vs 39.5% in patients) in metastatic groups (P =0.0356). Progesterone and estrogen receptor negativity was more frequent among metastatic patients carrying a Thr431 allele when compared to the nonmetastatic group.Discussion: Our resulsts are the first to demonstrate that Thr431Asn polymorphism of the ROCK2 gene could be a risk factor for the metastases of the breast cancer, and may help in predicting the prognosis.
Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 3038.
Collapse
Affiliation(s)
- M. Kalender
- 1Gaziantep University Medical Faculty, Gaziantep Oncology Hospital, Turkey
| | - S. Demiryürek
- 2Gaziantep University, Medical Faculty, Gaziantep School of Health, Turkey
| | - S. Oztuzcu
- 3Gaziantep University, Medical Faculty, Turkey
| | - A. Kizilyer
- 4Gaziantep University, Medical Faculty, Turkey
| | | | - A. Sevinc
- 6Gaziantep University, Medical Faculty, Gaziantep Oncology Hospital, Turkey
| | - M. Dikilitas
- 7Erciyes University, Faculty of Medicine, Turkey
| | - R. Yildiz
- 8Gazi University, Faculty of Medicine, Turkey
| | - C. Camci
- 9Gaziantep University, Medical Faculty, Gaziantep Oncology Hospital, Turkey
| |
Collapse
|
14
|
Kalender ME, Dirier A, Sevinc A, Camci C. Depression-anxiety and quality of life and the use of complementary and alternative medicine among breast cancer patients in Turkey. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-3130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Abstract #3130
Purpose: Breast cancer is the most common cancer type among women. The aim of this study was to examine the association between the use of complementary and alternative medicine (CAM) and quality of life, and anxiety and depression, and demographic characteristics of Anatolian women with breast cancer.
 Methods: Quality of life was measured with European Organization for Treatment and Research of Cancer (EORTC) quality of life core questionnaire (QLQ-C30, version 3.0) and anxiety and depression was measured with Hospital Anxiety and Depression Scale (HADS). The demographic characteristics of patients were filled by patient to a standard form.
 Results: Totally 122 patients with breast cancer were enrolled, and 50% (n=61) of patients reported that they were using CAM. The most commonly used CAM methods were stinging nettle (57%) and prayer and spiritual healing (49%). The statistical analysis showed that, there was a meaningful correlation between CAM usage and education level (p=0.031) and radiotherapy (p=0.002). There was no relationship between use of CAM and patients age, time since diagnosis, stage of cancer, chemotherapy using, smoking and residence. Analysis of patients showed a positive correlation between CAM and RF2 (Role Functioning) (p=0.014) and FI (Financial Difficulties) (p=0.011) and negative correlation between CAM and EF (Emotional Functioning) (p=0.033). There was no correlation between use of CAM and anxiety and depression scale. The RF2 (p=0.02), EF (p=0.047), FA (Fatigue) (p=0.038), PA (Pain) (p=0.043) and depression results (p=0.008) were better at patients with high education level. We analysed CAM using in patients living in rural or urban area, and the EF (p=0.006), CF (Cognitive Functioning) (p=0.027), PA (p=0.025), DY (Dyspnoea) (p=0.045) and DI (Diarrhoea) (p=0.000) results were better in urban area.
 Conclusions: According to the various studies in the literature, 20-83.3% of breast cancer patients were using CAM and the CAM methods are different in different countries and cultures. Our results suggest that the use of CAM among Anatolian women with breast cancer is popular. This study findings showed no correlation between anxiety and depression and CAM usage. There is a tendency to CAM usage in patients with financial problems. Emotional functioning was also worse in those patients. The study results showed that the use of CAM is more common among breast patients with bad emotional status and poor financial status.
Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 3130.
Collapse
Affiliation(s)
- ME Kalender
- 1 Gaziantep University Medicine School, Medical Oncology, Gaziantep, Turkey
| | - A Dirier
- 2 Gaziantep University Medicine School, Radiation Oncology, Gaziantep, Turkey
| | - A Sevinc
- 1 Gaziantep University Medicine School, Medical Oncology, Gaziantep, Turkey
| | - C Camci
- 1 Gaziantep University Medicine School, Medical Oncology, Gaziantep, Turkey
| |
Collapse
|
15
|
Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yılmaz U, Sagol O, Alacacioglu A. Cyclooxygenase-2 expression in gastrointestinal stromal tumours. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.15643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
16
|
Buyukberber S, Sari I, Camci C, Buyukberber NM, Sevinc A, Turk HM. Adrenomedullin expression does not correlate with survival in lung cancer. Med Oncol 2007; 24:245-9. [PMID: 17848751 DOI: 10.1007/bf02698047] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2006] [Revised: 11/30/1999] [Accepted: 12/16/2006] [Indexed: 11/27/2022]
Abstract
It is suggested that adrenomedullin (AM) plays a role in lung carcinogenesis although, to confirm this suggestion, further clinical studies are needed to determine its relationship with prognosis in lung cancer. Archived 50 paraffin-embedded tumor samples of the lung were retrospectively evaluated for AM expression by immunohistochemistry and analyzed for a possible correlation with patient characteristics and survival. Quantitation of immunoreactivity was accomplished using an immunohistochemical scoring system. The pulmonary resection specimens contained 22 squamous cell carcinomas, 15 adenocarcinomas, and 13 small cell carcinomas. Non-small cell carcinomas of the lung were more likely to express AM than small cell carcinomas of the lung. Ninety-one percent of squamous cell carcinomas and 87% of adenocarcinomas expressed AM at a moderate to strong level and grade2-4 (30-100%), which were significantly higher from the non-neo-plastic lung tissue. Twenty-three percent of small cell carcinomas of lung expressed AM. Interestingly, AM immunoreactivity was essentially weak and grade 1 (<%30) in this group. AM expression is upregulated in non-small cell carcinomas of the lung, whereas it is downregulated in small cell carcinomas and non-neo-plastic lung tissues. AM expression did not show any correlation with the differentiation of the tumor, the stage of cancer, and the overall survival of patients. These results did not support the role of adrenomedullin as an independent survival factor for lung cancer. However, AM inhibition in conjunction with other anti-angiogenic agents may be useful in the prevention and treatment of malignancies.
Collapse
Affiliation(s)
- S Buyukberber
- Department of Medical Oncology, Gazi University, Medical Faculty, Gazi Hospital, Ankara, 06500.
| | | | | | | | | | | |
Collapse
|
17
|
Rizvi S, Camci C, Yong Y, Parker G, Shrago S, Stokes K, Wright H, Sebastian A, Gurakar A. Is post-Lipiodol CT better than i.v. contrast CT scan for early detection of HCC? A single liver transplant center experience. Transplant Proc 2007; 38:2993-5. [PMID: 17112883 DOI: 10.1016/j.transproceed.2006.08.125] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2006] [Indexed: 11/29/2022]
Abstract
Hepatocellular carcinoma is a highly vascular neoplasm usually arising from a cirrhotic liver. Delayed, noncontrast, computed tomography (CT) imaging after 7 to 14 days reveals an oil-based contrast agent to be concentrated in the tumor but not in normal hepatic parenchyma. The aim of this study was to retrospectively correlate the post Lipiodol CT scan findings with respect to tumor size in the explanted liver. We retrospectively reviewed adult patients who had undergone orthotopic liver transplantation between November 1995 and December 2004 and also had an hepatic arteriogram with Lipiodol injection as part of their pretransplant workup. We calculated sensitivity, specificity, false-negativity, false-positivity, and accuracy of the test, as well as positive and negative predictive values. Lipiodol CT exam had sensitivity of 1.0; specificity of 0.6 with a calculated positive predictive value of 0.89 and a negative predictive value of 1.0. Overall accuracy of Lipiodol CT scan test was found to be 0.91, which was superior to an intravenous contrast CT alone. In conclusion, because of the higher sensitivity and accuracy values, hepatic arterial Lipiodol injection can be considered during the pretransplantation workup of high-risk cirrhotic patients, since the current model for End-stage Liver Disease scoring system for hepatocellular carcinoma is built on the ultimate bulk of the tumor. Further multicenter, controlled, large-volume prospective studies are warranted to verify this observation.
Collapse
Affiliation(s)
- S Rizvi
- Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Yilmaz M, Camci C, Sari I, Okan V, Sevinc A, Onat AM, Buyukhatipoglu H. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) mimicking systemic lupus erythematosus: a review of two cases. Lupus 2007; 15:384-7. [PMID: 16830886 DOI: 10.1191/0961203306lu2320cr] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Kikuchi-Fujimoto's disease (KFD), or histiocytic necrotizing lymphadenitis, is a benign and self-limited lymphadenitis commonly found in young women. It often shares clinical features with systemic lupus erythematosus (SLE), such as arthralgias, fever and leukopenia. The etiology of KFD remains unknown and controversial. Clinical course is favorable, with spontaneous remission in less than four months in almost all cases. Herein, we present two cases. The former is a 53-year old woman presenting with cervical lymphadenopathy, arthralgia, pancytopenia and positive antinuclear antibody (ANA). Lymph node biopsy revealed histopathological features compatible with Kikuchi-Fujimoto histiocytic necrotizing lymphadenitis. The latter patient was a 20-year old woman presenting with left cervical lympadenopathy, a butterfly rash that was reminiscent of SLE, and a positive antinuclear antibody. Based upon clinical, histological and laboratory findings, the diagnosis of SLE was excluded. Careful attention should be paid to differentiating between KFD and SLE, because of their similar presentations, yet different clinical courses and therapeutic requirements.
Collapse
Affiliation(s)
- M Yilmaz
- Department of Hematology, Gaziantep University, School of Medicine, Gaziantep, Turkey
| | | | | | | | | | | | | |
Collapse
|
19
|
Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, Nour B, Sebastian A. The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher 2006; 21:96-9. [PMID: 16142721 DOI: 10.1002/jca.20064] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Total plasma exchange (TPE) corrects coagulopathy in patients with liver disease and removes hepatotoxins/cytokines. This improvement is transient but can be used as a bridge until an organ is identified for liver transplantation (LTx) or the liver itself regenerates. Our aim was to retrospectively assess the efficacy of TPE in fulminant hepatic failure (FHF) and its impact on liver function tests. Between 1995-2001, 39 patients with FHF who had undergone TPE were reviewed. FHF was defined according to the O'Grady criteria based on the duration of encephalopathy as well as jaundice. TPE was performed using the Cobe Spectra TPE (Gambro) in Liver Intensive Care Unit, continued on a daily basis, until either adequate clinical response was achieved, the patient expired, or transplantation occurred. INR, PTT, Fibrinogen, ALT, AST, GGT, BUN, Ammonia, and Total Bilirubin were analyzed before and after TPE. Student's t-test and chi-square test and ANOVA were used for statistical analysis. Thirty-nine patients with FHF (31 females, 8 males with mean age of 32.3, range: 7-64) underwent TPE. Coagulopathy, hyperbilirubinemia, hyperammonemia were significantly improved (P < 0.05). Twenty-one patients survived (54%), 12 required LTx, and 18 patients (including one after LTx) expired. TPE was found to be significantly effective for correction of coagulopathy and improvement of liver tests. This intervention can be considered for temporary liver support until recovery or liver transplantation.
Collapse
Affiliation(s)
- M Akdogan
- Nazih Zuhdi Transplant Institute, INTEGRIS Baptist Medical Center, Oklahoma City, OK 73120, USA
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Buyukhatipoglu H, Sevinc A, Camci C, Buyukberber S, Sari I. A case representing coexistence of acute myeloblastic leukemia and dedifferentiated liposarcoma: the possible role of chemotherapy in triggering dedifferentiation. ACTA ACUST UNITED AC 2006; 28:343-6. [PMID: 16999727 DOI: 10.1111/j.1365-2257.2006.00806.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Acute myelogenous leukemia (AML) is a hematological disorder that is characterized by an abnormal proliferation of immature myeloid cells. Dedifferentiated and well-differentiated liposarcomas are the two pathological subtypes of liposarcoma, based on the WHO classification. Transition from well-differentiated to dedifferentiated liposarcoma is a well-recognized phenomenon. Well-differentiated tumors are known to have low malignancy grade. However, when dedifferentiation occurs, the tumor acquires the aggressive features of a fully malignant lesion. This process largely is believed to progress in a time-dependant manner; however, time is not the only factor of importance. The potential roles of other factors in this transition are still unclear. To date, the coexistence of AML and liposarcoma has not been reported in the literature. In this paper, we report on a case of coexistence of AML and liposarcoma, and on the unusual behavior of a well-differentiated tumor after dedifferentiation occurs.
Collapse
Affiliation(s)
- H Buyukhatipoglu
- Division of Medical Oncology, Gaziantep Oncology Hospital, Gaziantep University, Gaziantep, Turkey
| | | | | | | | | |
Collapse
|
21
|
Camci C, Gurakar A, Rose J, Rizvi S, Wright H, Bader T, Monlux R, Schade RR, Nour BM, Sebastian A. Liver transplantation for hepatitis B in the United States. Transplant Proc 2006; 37:4350-3. [PMID: 16387118 DOI: 10.1016/j.transproceed.2005.10.017] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2005] [Indexed: 01/08/2023]
Abstract
AIM To evaluate the impact of hepatitis B virus (HBV) on US health care system, we reviewed the Organ Procurement and Transplantation (OPTN, formerly UNOS) HBV database. METHOD We reviewed records of liver transplantations (LTx) performed in the United States listed for the diagnoses of HBV between 1993 and mid-October 2004. Both acute as well as chronic cases were included. Coinfection with hepatitis C virus was excluded from study. The specific states selected for review were chosen from those areas that are receiving large numbers of new immigrants from high HBV endemic areas (ie, Texas, Pennsylvania, California, New York, and Florida). One-, 3-, and 5-year patient survival rates for both cadaveric and living related donors were analyzed. Survival rates were obtained from OPTN database as Kaplan-Meyer survival test. RESULTS Between 1993 and mid-October 2004, 53,312 LTx had been performed nationwide. Of these, 2314 (4.34%) were performed for the diagnosis of HBV; 1816 cases (78%) were due to chronic HBV infection (45 of them were living donor LTx) and 498 cases (22%) were due to HBV-induced acute liver failure (seven of them were living donor LTx). Three- and 5-year survival rates of chronic HBV-related LTx patients were better than acute HBV-related and overall LTx patients. CONCLUSION HBV is generally considered to have a minor health significance by many community gastroenterologists. With growing immigration from overseas, it may eventually have a higher impact on LTx. Therefore, it is crucial to further educate gastroenterologists and primary care physicians caring for this specific group of patients.
Collapse
Affiliation(s)
- C Camci
- Nazih Zuhdi Transplant Institute, Integris Baptist Medical Center, Oklahoma City, Oklahoma 73112, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
Gastric cancer (GCa) is still a common cause of cancer-related deaths worldwide, despite improved diagnostic and therapeutic implications. Hence, early diagnosis has critical importance. Flow cytometry reveals rapid and reproducible quantification of nuclear DNA content of disaggregated tissues and assessment of its significance in various malignant and precancerous lesions. A total of 121 patients with GCa, chronic atrophic gastritis (CAG), gastric polyps, intestinal metaplasia (IM) and gastric dysplasia and 36 healthy controls were enrolled in this study. Flow cytometric measurements of DNA ploidy, total S-phase, G2M-phase and proliferative indexes (PIs) were analysed on fresh gastric biopsy specimens obtained by gastroscopy. DNA aneuploidy was present in 43.75% of the GCas (p < 0.05). We found a DNA aneuploidy rate of 15.38% in CAG, 15.38% in IM and 25% in epithelial dysplasia. One of nine polyps had aneuploidy. None of the normal gastric mucosa samples showed aneuploidy. The controls had lower rates of total S-phase and PIs (p < 0.05). In conclusion, DNA flow cytometry may be offered as an objective diagnostic tool for early detection of malignant transformation in gastric lesions.
Collapse
Affiliation(s)
- M H Yasa
- Department of Gastroenterology, School of Medicine, Ondokuz Mayis University, Samsum, Turkey.
| | | | | | | | | | | |
Collapse
|
23
|
Camci C, Akdogan M, Gurakar A, Gilcher R, Rose J, Monlux R, Alamain S, Wright H, Sebastian A, Nour B. The impact of total plasma exchange on early allograft dysfunction. Transplant Proc 2005; 36:2567-9. [PMID: 15621091 DOI: 10.1016/j.transproceed.2004.09.071] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
INTRODUCTION Early allograft dysfunction (EAD) is a rare but serious complication encountered among patients undergoing liver transplant surgery. Total plasma exchange (TPE) in EAD has been suggested, but its role is still considered investigational. We retrospectively assessed the efficacy of TPE in EAD and its impact on other parameters of liver function. MATERIALS AND METHODS Between 1995 and 2001, 25 orthotopic liver transplant recipients developed EAD, which was defined as early postoperative prothrombin time (PT) >17 seconds, aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) >2500 IU/L, and/or the presence of hepatic encephalopathy, and development of renal failure. Daily TPE was performed using the Cobe Spectra TPE (Gambro) for 4 hours until an adequate clinical response, the patient underwent retransplantation, or the patient died. International normalizing ratio (INR), partial thromboplastin time (PTT), fibrinogen, ALT, AST, gamma-glutanyl transpeptidase (GGT), blood urea nitrogen (BUN), ammonia, and total bilirubin were analyzed before and after TPE. Student t and chi-square tests were used for statistical analysis. RESULTS Twenty-five patients with EAD included 13 females, 12 males of mean age 42.3 years (range, 1-63 years). Coagulopathy and hyperbilirubinemia significantly improved with TPE. Nineteen patients (76%) survived and 2 required retransplantation. Mean number of TPE sessions was 4.3. CONCLUSION TPE was effective to correct coagulopathy and improve liver function. These results suggest the benefit of potential temporary liver support until recovery or retransplantation, in the absence of sepsis or multi-system organ failure.
Collapse
Affiliation(s)
- C Camci
- Integris Baptist Medical Center
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
|
25
|
Ozdarendeli A, Camci C, Aygen E, Kirkil C, Toroman ZA, Dogru O, Doymaz MZ. SV40 in human thyroid nodules. J Clin Virol 2004; 30:337-40. [PMID: 15163424 DOI: 10.1016/j.jcv.2003.12.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 12/12/2003] [Accepted: 12/23/2003] [Indexed: 11/21/2022]
Abstract
BACKGROUND Simian virus 40 (SV40) has been a model experimental system for the study of cell transformation and tumorigenesis for many years. The study of SV40 in humans has aroused interest in the related BK virus (BKV) and JC virus (JCV) and their role in human disease. OBJECTIVES SV40 has been found in a variety of human samples, both malignant and normal. Many independent studies have suggested that SV40 plays a role for some cancers. However, in most cases the role of SV40 remains unclear. STUDY DESIGN The subject of this study consisted of 99 patients with thyroid nodules. Both thyroid nodule and normal thyroid tissue were taken from each patient to test whether they contained SV40 sequences. RESULTS We detected SV40 sequences by polymerase chain reaction (PCR) in four of 99 thyroid nodules. Two of them were papillary thyroid carcinomas and the others were benign thyroid nodules. No SV40 was detected in 99 of normal thyroid tissues of the same patients. DNA sequence analysis, performed in four positive samples, confirmed that PCR products belong to the SV40 T antigen (Tag) region. CONCLUSION The possible role of SV40 in the development of thyroid nodules and the spread of SV40 by horizontal infection in the human population are discussed.
Collapse
Affiliation(s)
- A Ozdarendeli
- Department of Microbiology and Clinical Microbiology, College of Medicine, Firat University, Elazig, Turkey.
| | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
BACKGROUND Laparoscopic procedures are safe and effective treatment methods in experienced hands. However, complications have been reported for laparoscopic procedures. One of the complications of laparoscopic cholecystectomy is vascular injuries. Hepatic and cystic artery injuries may occur alone or in association with bile duct injury. Bleeding from arterial injury may be seen during operation or in the late postoperative period. One of the most significant pathologies leading to this rare phenomenon is hemobilia. METHODS We present a case of a 62-year-old woman who underwent routine laparoscopic cholecystectomy for cholelithiasis at another hospital. She presented 6 months later with the clinical feature of upper gastrointestinal bleeding. RESULTS There was a 42 x 40 x 11 mm anechoic lesion and an echoic pattern compatible with a metallic object was found in the subhepatic region using abdominal ultrasonography. In the endoscopic examination, fresh blood was found in the stomach. The source of hemorrhage could not be identified. Bulbus duodeni was normal but a fresh clot on the papilla of Vateri was seen on gastroduodenoscopic examination. Laparotomy was performed and the provisional diagnosis of hemobilia was reached. The injured hepatic artery and pseudoaneurysmatic structure were repaired. CONCLUSION Hemobilia is a late complication of laparoscopic cholecystectomy. We believe that it is important to take into consideration that bile duct injuries may be accompanied by arterial pathology.
Collapse
Affiliation(s)
- O Dogru
- General Surgery Department, Firat University School of Medicine, 23200 Elazig, Turkey,
| | | | | | | | | |
Collapse
|
27
|
Büyükberber N, Büyükberber S, Kadayifci A, Guney C, Camci C, Balkan A, Kubar A, Turk HM, Sevinc A. The prevalence of hepatitis G virus in cancer patients. New Microbiol 2003; 26:243-8. [PMID: 12901419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
Abstract
Hepatitis G virus (HGV) is transfusion-transmissible and has a global distribution. However, its frequency and clinical impact have not been well established in extrahepatic cancer patients. In this study, we determined the prevalence of HGV RNA positivity, and its relationship with history of transfusion, amount of transfusion, age and sex in patients with hematological and solid malignancies in Southeastern Turkey. Sixty-one patients (35 males and 26 females) followed up for various malignancies and 60 healthy subjects were included in the study. HGV RNA was investigated by the reverse transcription polymerase chain reaction. HGV RNA was detected in none of the patients with cancer (0%) and only one person (1.6%) in the control group. There was no difference between the groups. This observation indicates that the prevalence of HGV is very low in cancer patients and healthy people in our geographical area. In addition, the role of HGV in the pathogenesis of extrahepatic malignancies seems insignificant.
Collapse
Affiliation(s)
- N Büyükberber
- Gaziantep University, Medical Faculty, Department of Molecular Biology, Gaziantep, Turkey
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Camci C, Büyükberber S, Tarakçioğlu M, Adam SM, Camci C, Türk HM, Büyükberber N, Balat O. The effect of continuous ambulatory peritoneal dialysis on serum CA-125 levels. EUR J GYNAECOL ONCOL 2003; 23:472-4. [PMID: 12440830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Malignant and non-malignant serosal fluids were found to be associated with high serum levels of CA-125, suggesting that the presence of fluid in the serosal cavities may stimulate its release. In this study, we investigated the relationship between serum CA-125 levels and peritoneal irritation during continuous ambulatory peritoneal dialysis (CAPD). We performed a clinical study in 24 stable patients (15 amenstrual females and 9 males), aged 46 +/- 14 years on CAPD. The control group consisted of 32 healthy volunteers (20 females, 12 males) aged 44 +/- 12 years. CA-125 levels were determined prior to the CAPD dwell (without dialysate in abdomen) and during the CAPD dwell (dialysate in abdomen 4 hours after). As a result, serum CA-125 levels were found to be 14.86 +/- 5.98 U/ml and 15.23 +/- 6.05 U/ml respectively, whereas it was 8.32 +/- 5.54 U/ml in the control group. Serum CA-125 levels were found to be significantly elevated in CAPD patients when compared with healthy volunteers. However, serum CA-125 levels detected prior to and after CAPD did not differ between the groups. Interestingly, all of the patients in our study group were detected to have normal serum CA-125 levels (< 35 U/ml). We concluded that CAPD-induced abdominal artificial ascites did not affect serum levels of CA-125. Moreover, short and non-inflammatory mechanical pressures in the CAPD procedure do not have any effect on serum CA-125 levels.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Oncology, Adana, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Camci C, Balat O. Neoadjuvant chemotherapy in ovarian cancer. EUR J GYNAECOL ONCOL 2003; 23:437-41. [PMID: 12440820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Patients with advanced ovarian cancer have a chance of less than 50% after radical debulking surgery. In spite of the currently more effective combination chemotherapy agents that have become available as adjuvant therapy in the last decade, the prognosis of patients with residual tumor mass larger than 1 cm in diameter following surgery is still poor. Neoadjuvant or primary chemotherapy has been suggested as an alternative approach to primary laparotomy of the bulky ovarian cancer. The advantages and available data on neoadjuvant chemotherapy are discussed in this review.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Medical Oncology, Turkey
| | | |
Collapse
|
30
|
Aydin A, Kutlar I, Camci C. Ruptured granulosa cell tumor of the left ovary and mature cystic teratoma of the right ovary: a case report of unusual acute abdominal syndrome. EUR J GYNAECOL ONCOL 2002; 22:350-1. [PMID: 11766738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
Although granulosa cell tumor combined with a dermoid cyst in the same ovary is rarely seen, adult granulosa cell tumor of the ovary with contralateral teratoma has not been reported to date. In this report we present the first case in the English language literature of a ruptured granulosa cell tumor of the left ovary and mature cystic teratoma of the right ovary presenting as acute abdominal syndrome. The patient underwent total abdominal hysterectomy, bilateral-ophorectomy, and multiple pelvic lymph node sampling and infracolic omentectomy. She received combined chemotherapy consisting of bleomycin, etoposide. and cisplatin for six cycles. Subsequent follow-up and workups have revealed no evidence of disease. At 19 months after initial diagnosis, she is disease-free.
Collapse
|
31
|
Abstract
Wilms' tumor occurs rarely in adults, especially after the third decade. In adults, the prognosis of Wilms' tumor is worse than in children. In this case report, we present a 48-year old patient who relapsed with advanced stage shortly after primary surgery. A definitive treatment plan has not been established because of the rarity of this tumor in adults. After surgical removal, multimodal therapy should be begun immediately for long-lasting, complete remission.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Medical Oncology, Gaziantep, Turkey.
| | | | | | | | | | | |
Collapse
|
32
|
Camci C, Guney C, Balkan A, Buyukberber N, Buyukberber S, Kadayifci A, Kubar A. The prevalence of TT virus in cancer patients. New Microbiol 2002; 25:463-8. [PMID: 12437226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Transfusion-transmitted virus (TTV) is a recently discovered transfusion-transmissible DNA virus. Its frequency and clinical impact has not been established in cancer patients in Turkey. In this study, we determined the prevalence of TTV DNA positivity, and its relationship with history of transfusion, amount of transfusion, age and sex in patients with hematological and solid malignancies. Sixty-one patients (35 male and 26 female) followed up for various malignancies and 45 healthy subjects were included in the study. ITV DNA was assayed by the polymerase chain reaction (PCR). TTV DNA was detected in 18 of 61 patients (29.5%) and in 5 of 45 control subjects (11.1%). In cancer patients, the prevalence of TTV DNA positivity was higher to comparison with control group. In addition, the prevalence of TTV DNA positivity was significantly higher in 22 patients who had a history of blood transfusion in the last 6 months than 39 patients who had no current or past history of transfusion (40.9% vs 23.0% respectively). These results suggest that the prevalence of TTV DNA is high and the parenteral route is an important mode of transmission for TTV in cancer patients. In addition, the high prevalence and persistence of TTV in cancer patients with parenteral risk exposure could be related to the immunodeficiency due to cancer and high viral loads by parenteral route.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Clinical Oncology, Turkey
| | | | | | | | | | | | | |
Collapse
|
33
|
Okan V, Araz M, Camci C, Aktaran S, Sahin A, Buyukberber S, Bakir K, Cakmak EA. Bernard-Soulier syndrome in a Turkish family. Int J Clin Pract 2002; 56:546-8. [PMID: 12296619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
Abstract
This report describes the first Turkish family to be diagnosed with Bernard-Soulier syndrome. The family consists of nine members (two parents, three sons and four daughters). The parents were first cousins. The index case, a 22 year-old-man, had a history of haemorrhagic diathesis with thrombocytopenia, giant platelets in the peripheral blood smear and a prolonged bleeding time. Refractory idiopathic thrombocytopenic purpura had been diagnosed elsewhere and a splenectomy had been performed six months previously. Ristocetin agglutination of platelets was defective and flow cytometry analysis of platelet membrane glycoprotein showed markedly reduced expression of glycoprotein lb (2.1%). Bernard-Soulier syndrome was diagnosed. Increased mean platelet volume was found in both parents, one son and three daughters. The other son and daughter were normal.
Collapse
Affiliation(s)
- V Okan
- Department of Internal Medicine, University of Gaziantep, School of Medicine, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Uzol O, Camci C. Experimental and computational visualization and frequency measurements of the jet oscillation inside a fluidic oscillator. J Vis (Tokyo) 2002. [DOI: 10.1007/bf03182334] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
35
|
Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, Bayraktar N. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 2002; 39:117-22. [PMID: 12357295 DOI: 10.1007/s005920200029] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Diabetes is associated with a significant increase in thiobarbituric acid reactive substances (TBARS) which are considered as an index of endogenous lipid peroxidation. The human body has a complex antioxidant defense system that prevents the initiation of free radical chain reactions. We measured plasma TBARS levels, superoxide dismutase (SOD) and catalase (CAT) activities and compared their relation to the metabolic control of diabetes and diabetic microangiopathy. Sixty-four patients (19 men), aged 52.35+/-9.31 years with type 2 diabetes mellitus were included in the study. Thirty-six healthy subjects (12 men), aged 51.02+/-7.01 years formed the control group. TBARS levels and SOD activity were elevated in the diabetic group when compared with the control group ( p<0.001 and p<0.00001, respectively). However CAT activity was significantly decreased in the diabetic group when compared with the control group ( p<0.00001). Patients with diabetic nephropathy and retinopathy, but not neuropathy, had elevated TBARS levels but there was no statistically significant difference when compared with diabetic patients without microangiopathy ( p>0.05). There was a positive correlation between plasma TBARS levels and SOD activity (r=0.770, p=0.0001) and a negative correlation between plasma TBARS levels and CAT activity (r=0.482, p=0.0001). There was also a negative correlation between SOD and CAT activities (r=-0.609, p=0.0001). We found significantly elevated TBARS levels in diabetic patients. We did not observe any correlation between TBARS levels and blood glucose and HbA(1c) levels. Elevated TBARS levels and SOD activity and decreased CAT activity may be due to a compensation mechanism of the body.
Collapse
Affiliation(s)
- H M Turk
- Department of Internal Medicine, Sahinbey Medical Center, Gaziantep University, School of Medicine, Gaziantep, Turkey
| | | | | | | | | | | | | |
Collapse
|
36
|
Balat O, Aydin A, Camci C, Kutlar I, Büyükberber S. Bilateral primary squamous cell carcinoma of the ovary: a case report of isolated metastasis to the lateral pelvic wall. EUR J GYNAECOL ONCOL 2002; 22:445-6. [PMID: 11874078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
Primary squamous cell carcinoma of the ovary is rare. The majority of cases arise most commonly from the lining of a dermoid cyst, and less often in endometriosis or a Brenner tumor. A 40-year-old woman underwent exploratory laparotomy and was found to have a right ovarian tumor adherent to the lateral pelvic wall with no ascites. She underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy, pelvic lymphadenectomy, infracolic omentectomy, appendectomy, and right nephrectomy for bilateral primary squamous cell carcinoma of the ovary. She was started on multiagent chemotherapy. On follow-up after two years the patient had died of cerebral metastases. To our knowledge in this report we present the first case in the English literature of bilateral pure squamous cell carcinoma of the ovary.
Collapse
Affiliation(s)
- O Balat
- Department of Obstetrics and Gynecology, University of Gaziantep, Sahin Bey Medical Center, Turkey
| | | | | | | | | |
Collapse
|
37
|
Abstract
We report a case of a 51-year old man with small cell lung cancer who developed superior vena cava syndrome due to obstruction of the superior vena cava at the junction of the brachiocephalic vein by a fibrotic band, 2 months after completing six cycles of chemotherapy with cisplatin and etoposid. Superior vena cava syndrome caused by chemotherapy-induced pulmonary fibrosis should be kept in mind during follow-up.
Collapse
Affiliation(s)
- H M Turk
- Gaziantep University, Faculty of Medicine, Department of Medical Oncology, Turkey
| | | | | | | | | | | | | |
Collapse
|
38
|
Tarakçioglu M, Erbagci A, Cekmen M, Usalan C, Ciçek H, Ozaslan J, Camci C. Acute effect of haemodialysis on serum markers of myocardial damage. Int J Clin Pract 2002; 56:328-32. [PMID: 12137438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
Cardiac markers are more likely to be elevated in dialysis patients than in patients with renal failure not on dialysis. In this study, 31 patients (20 males, 11 females) undergoing chronic haemodialysis were enrolled. The effect of haemodialysis on cardiac troponin T (cTnT), I (cTnI), creatine kinase MB (CKMB) mass, CKMB activity and myoglobin assays was assessed by comparing pre- and post-haemodialysis determinations. After correcting for haemoconcentration, significant differences were observed (mean +/- SEM, pre- vs post-dialysis) for myoglobin (178.9 +/- 19.3 vs 225.0 +/- 28.4 ng/ml; p=0.006) for cTnT (0.111 +/- 0.028 vs 0.148 +/- 0.037 ng/ml; p=0.004), for CKMB mass (2.75 +/- 0.37 vs 2.59 +/- 0.37 ng/ml; p=0.000) and CKMB activity (14.8 +/- 0.9 vs 13.1 +/- 0.9 U/l; p=0.000) assays. Our study questions the reliability of cardiac markers in dialysis patients and suggests that the clinical threshold value and diagnostic efficiency of each assay needs to be validated. Although these differences exceeded clinical threshold values in only a few patients, serum markers of myocardial damage in dialysis patients should be interpreted with caution.
Collapse
Affiliation(s)
- M Tarakçioglu
- Department of Biochemistry, Faculty of Medicine, Gaziantep University, Turkey
| | | | | | | | | | | | | |
Collapse
|
39
|
Camci C, Sari R, Buyukberber S, Kutlu R, Sevinc A, Cokkeser Y. Non-invasive imaging methods before fine-needle aspiration in the diagnosis of cervical masses. Int J Clin Pract 2002; 56:147-8. [PMID: 11926703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/24/2023] Open
Abstract
A carotid body tumour is a vascular tumour usually located at or around the bifurcation of the carotid artery and originating from the tunica adventitia. Carotid body tumours, which are generally non-functional and asymptomatic, grow slowly, which is why diagnosis can be delayed. Because of the vascular structures, fine-needle aspiration biopsy may be dangerous and impractical. Efficient and reliable methods of diagnosis, such as colour Doppler ultrasound, magnetic resonance imaging, computerised tomography and arteriography, can be useful. We report on a 58-year-old woman with diarrhoea, flushing and a cervical, hard, non-tender, fixed mass. An unsuccessful diagnostic fine-needle aspiration biopsy was performed after palpation of the cervical mass. A carotid body tumour was finally diagnosed. We concluded that non-invasive imaging methods should be evaluated before fine-needle aspiration in cervical masses. It should also be kept in mind that asymptomatic cervical masses may be related to non-local symptoms.
Collapse
Affiliation(s)
- C Camci
- Department of Medical Oncology, Gaziantep University School of Medicine, Sahinbey Medical Centre, Turkey
| | | | | | | | | | | |
Collapse
|
40
|
Sari R, Camci C, Kutlu R, Totan Y, Sevinc A, Buyukberber S. The efficacy of acetazolamide on visual functions in a patient with choroid metastasis of breast carcinoma. Int J Clin Pract 2001; 55:488-90. [PMID: 11594263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/21/2023] Open
Abstract
Breast carcinoma is the most frequent cancer in women and is the second leading cause of death. Choroid metastasis of breast carcinoma can be found either at presentation or in remission. It is frequently encountered in disseminated breast cancer with multiple organ metastasis. It has been proposed that the oedema-reducing effect of acetazolamide is due to stimulated ion and fluid removal from the retina to the choroid. A 40-year-old female patient on adjuvant chemotherapy for breast cancer was found to have an isolated choroid metastasis. Clinical and radiological remission was achieved after orbital radiotherapy, chemotherapy and acetazolamide treatment. In this case report, we emphasise the possible beneficial effect of acetazolamide in patients with choroid metastasis.
Collapse
Affiliation(s)
- R Sari
- Department of Internal Medicine, Inonu University School of Medicine, Malatya, Turkey
| | | | | | | | | | | |
Collapse
|
41
|
Sari R, Camci C, Sevinc A, Demirbilek O, Ertas E, Buyukberber S. The effect of abdominal surgery on serum CA-125 levels. CLIN EXP OBSTET GYN 2001; 27:244-5. [PMID: 11214965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
42
|
Camci C, Sari R, Sevinç A, Büyükberber S. Dacarbazine-induced carotid artery and deep venous thrombosis in a patient with leiomyosarcoma: case report. J Chemother 2001; 13:206-9. [PMID: 11330370 DOI: 10.1179/joc.2001.13.2.206] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Thromboembolic events are a common and important cause of morbidity and mortality in cancer patients that require early diagnosis and treatment. Reports have suggested that chemotherapeutic agents may contribute to this risk. In this case report, a 60-year-old male patient on chemotherapy (dacarbazine and doxorubicin) for leiomyosarcoma with no previous history of thromboembolism developed left carotid artery thrombosis 3 days after the first cycle of chemotherapy. A low molecular weight heparin was started for a possible cerebrovascular accident-related thrombosis. In the second cycle, he developed right femoral vein thrombosis only 2 days after initiating the chemotherapy. The chemotherapy protocol was changed and the patient did not develop any thrombosis during the 1-year follow-up. In the literature, no thrombotic complications have previously been reported due to either dacarbazine or doxorubicin. In conclusion, elderly patients on chemotherapy should be carefully monitored for thromboembolic complications and, in case of thrombosis, the chemotherapy protocol should be changed.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Faculty of Medicine, Department of Medical Oncology, Turkey.
| | | | | | | |
Collapse
|
43
|
Sevinc A, Sari R, Camci C, Buyukberber S. A secondary interpretation is needed on serum CA 125 levels in case of serosal involvement. J R Soc Promot Health 2000; 120:268-70. [PMID: 11197456 DOI: 10.1177/146642400012000420] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
44
|
Sönmez HM, Başak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, Ertin I, Celik SC. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey. J Hum Hypertens 1999; 13:399-404. [PMID: 10408590 DOI: 10.1038/sj.jhh.1000824] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Hypertension is an important public health problem, with some variability of its epidemiological properties in different populations. OBJECTIVES The purpose of this study was to estimate the prevalence of hypertension and to determine the hypertension awareness, treatment and control rates in Aydin, a Turkish province. METHODS Of 1600 coincidentally selected people aged over 18 years in Aydin, 1480 (92.5%) had their blood pressure (BP) measured and answered a standard questionnaire in 1995. RESULTS Estimates of the prevalence of hypertension and its control were computed using two different criteria to define hypertension: BP > or =140/90 mm Hg or on treatment and BP > or =160/95 mm Hg or on treatment. Overall, the estimated prevalence of hypertension was 29.6% (for BP > or =140/90 mm Hg or on treatment). Hypertension prevalence increased progressively with age, from 9% in 18- to 29-year-olds to 70.6% in those 70-79 years of age. Women had a significantly higher prevalence than men (34.1% vs 26.0% respectively). Overall, 57.9% of hypertensive individuals were aware that they had high BP, and 82.1% of aware hypertensives were being treated with antihypertensive medications, but only 19.8% of treated hypertensives were under control (systolic pressure <140 mm Hg and diastolic pressure <90 mm Hg). In addition, housewives, unemployed, and the less educated individuals had greater mean systolic and diastolic BP. CONCLUSIONS Our results indicate that hypertension is highly prevalent in Aydin, Turkey, and the detection and control of hypertension is unsatisfactory.
Collapse
Affiliation(s)
- H M Sönmez
- Department of Internal Medicine, Adnan Menderes University, Aydin, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
45
|
|